Fosravuconazole
Modify Date: 2024-01-05 16:10:49
Fosravuconazole structure
|
Common Name | Fosravuconazole | ||
|---|---|---|---|---|
| CAS Number | 351227-64-0 | Molecular Weight | 547.47100 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H20F2N5O5PS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FosravuconazoleFosravuconazole is a prodrug of ravuconazole, with antifungal activity. |
| Name | [(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-yl]oxymethyl dihydrogen phosphate |
|---|---|
| Synonym | More Synonyms |
| Description | Fosravuconazole is a prodrug of ravuconazole, with antifungal activity. |
|---|---|
| Related Catalog | |
| Target |
Fungal[1] |
| In Vitro | Fosravuconazole (BMS-379224) is a prodrug of ravuconazole, with antifungal activity[1]. |
| In Vivo | Fosravuconazole (BMS-379224) is rapidly conversed to ravuconazole upon iv administration to rats. Fosravuconazole shows comparable efficacy at inhibiting C. albicans infection model in mice as orally administered ravuconazole[1]. |
| References |
| Molecular Formula | C23H20F2N5O5PS |
|---|---|
| Molecular Weight | 547.47100 |
| Exact Mass | 547.08900 |
| PSA | 181.43000 |
| LogP | 4.33408 |
| Benzonitrile,4-(2-((1R,2R)-2-(2,4-difluorophenyl)-1-methyl-2-((phosphonooxy)methoxy)-3-(1H-1,2,4-triazol-1-yl)propyl)-4-thiazolyl) |
| UNII-L4Q6O5430L |